mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
1e-05 |
mRNA |
AZD6244 |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0002 |
mRNA |
nelarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0002 |
mRNA |
AT-406 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
0.0002 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0002 |
mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0003 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0004 |
mRNA |
GDC-0879 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0009 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.001 |
mRNA |
ruxolitinib |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |